Abnormal eating behavior among obese and its correction methods ab 48.99 € als Taschenbuch: Monograph. Aus dem Bereich: Bücher, Wissenschaft, Medizin,
Obesity in many Western Countries has cost communities billions of dollars. Improving the health of community members by dietary restriction, anti-obese foods and physical activity has become important to maintain weight loss. Over weight individuals have numerous health conditions that include heart disease, depression, hypertension, hypercholesterolemia and diabetes. Interests in low fat diets and anti-obese drugs on brain function that determines the body fat metabolism and energy expenditure has become important to the correction of numerous metabolic diseases associated with obesity. The excess intake of calories and the poor body metabolism has become a community problem. The balance between the consumption of calories and the metabolism of calories is controlled by the brain with appetite control regulated by interactions between the gut, adipose tissue and the brain. Early in life brain endocrine disorders such as hormone imbalances leads to appetite dysregulation with overeating. In obesity the abnormal metabolism of sugars and fats by the the liver and other tissues leads to hypercholesterolemia and heart disease.
Obesity is characterized by abnormal or excessive fat accumulation that is the result of a chronic imbalance between energy intake and energy expenditure. The aim of this study is to estimate the concentrations of leptin, T3 hormone, T4 hormone, TSH, MDA, GSH, Zn, Mg, lipid profile (cholesterol, HDL-c, LDL-c, VLDL-c, and triglycerides), atherogenic index, glucose and BMI in all the study samples, study the correlation between leptin and other biochemical parameters including: T3hormone, T4hormone, TSH, MDA, GSH, Zn, Mg, lipid profile, atherogenic index and glucose among obese individuals and the control group. This study was conducted from the beginning of January 2015 until the end of October 2015. Blood samples have been collected from a total 176 persons. All individuals were randomly taken from private laboratories in Kirkuk Governorate, and their ages were between 20-55years. Blood samples were divided into three groups according to BMI. Group one - control group (Normal weight): 66 individual (32males, 34females), BMI (18.5 - 24.9 kg/m2). Group two- overweight group: 50 individual (16males, 34females), BMI (25.0 - 29.9 kg/m2).
The X-ray medical imaging is one of the dependent techniques which used in the diagnosis of the patient without resorting to surgical intervention. It considers as the relatively low cost of examination and availability in the public and private sectors. X-ray is also characterized by its ability to provide good anatomical information about bones and interference among bones and soft tissues, but is relatively unable to provide complete anatomical information about the soft tissues which located in the same site or to show the boundaries between these tissues or to distinguish between normal and abnormal soft tissues Which has a negative effect on the diagnostic ability of X-ray medical imaging. To overcome these obstacles, the contrast agents (iodine-based) were used with X-ray medical imaging for the 50 years ago, the use of these chemical components has side effects such as( kidney failure, heart stroke, negative effects on the liver and spleen) and use restrictions such as lack of Imaging time and poor contrast for obese patients. Gold nanoparticles overcome most of these restrictions with low toxicity due to its size and properties and allow for a long time of imaging.
The key goal of this book is to provide insight about the effect of obesity on the central and peripheral nervous system by using autonomic function tests and reaction time studies. It would cater to medical students and health professionals. Important features: Effect of obesity on autonomic function test Effect of obesity on auditory reaction time Effect of obesity on visual reaction time Methods to do autonomic function tests and reaction time studies Emphasizes on understanding the fact that abnormal autonomic function and reaction time predisposes obese to future cardiovascular and neurological complications
This publication is devoted to the pressing problems of obesity and their scrutiny. Data presented includes fresh information on classification and diagnostics of obesity and eating disorders, physiology and pathophysiology of abnormal eating behavior among obese and its correction methods. The treatment of abnormal eating behavior among obese manifestations has become a critical issue. The book includes findings on etiology and pathogenesis of the obesity and introduces up-to-date treatment methods. A separate chapter presents data collection of authors of pathological eating behaviors among obese. The book is intended for the use in professional education, further training of general practitioners and by students of medical schools.
Globally, 10% of all children and 43 million children under 5 years are either overweight or obese (Livingstone, 2014). This statistic indicates there is a 60 % increase in childhood obesity over two decades. Obesity is defined as "abnormal or excessive fat accumulation that might have a negative impact on health" (WHO, 2013). This book was designed to explore children's (aged 9-10) beliefs about healthy eating and what they manage to eat healthily. Because of each cohort findings were analyzed, presented and discussed separately, and because of that each cohort had different context and background, therefore, each group needs a distinct conclusion. Moreover, children had difficulty to make healthy choices among certain foods such as fresh vs fried fruits (57%) and vegetables, food low and high in fat (57%), sugar (57%) and salt (57%), and boiled and fried potatoes (42.8%). All these findings revealed that there were areas of partial understanding or misconception of children in this group that is essential to be addressed and tackled to help to avoid childhood obesity.
It has become increasingly difficult to keep up with the growing body of literature on the genetics, metabolic phenotype and treatment of obesity. This volume brings together an array of chapters from many of the foremost authorities and researchers in this area. Key advances in the genetics of obesity are summarized and the effects of obesity in pregnancy, childhood and old age explored. By scrutinizing the hormones and enzymes most recently implicated in the development, maintenance and consequences of obesity, the biochemical and physiological background of the abnormal metabolism of obesity is mapped out. Furthermore, a practical update on clinical approach and treatment of obesity is offered. Finally, the social aspects of obesity and the view of the obese body in art throughout the centuries are reflected. A valuable overview of causes, metabolic disturbances and treatment options, this volume will appeal to those with an interest in clinical as well as pathophysiological and genetic aspects of obesity. Furthermore, it will provide useful reading for scientists and students who would like to broaden and update their knowledge in this area.
Obesity is currently regarded as one of the major health challenges of the developed world. Excess body weight is an important risk factor for morbidity and mortality from cardiovascular diseases, diabetes, cancer, musculoskeletal disorders and even psychiatric problems and is estimated to cause nearly 3 million deaths per year worldwide. Obesity is not necessarily associated with comorbidities: there are indeed metabolically healthy obese individuals. Thus, we need to consider individuals presenting simple with obesity separately from those at risk of developing or who have already developed complex clinical states potentially leading to disability. Comorbidities can tip the balance of independence in patients who already have functional limitations mainly due to the excess of mass itself or who develop conditions such as diabetes, cardiovascular conditions, non-alcoholic fatty liver disease, where an abnormal metabolism of adipose tissue prevails. Morbid obesity with comorbidities leading to disability represents a real social and economic burden for National Health Systems worldwide. The presence of multiple and associated comorbidities often represents an obstacle to being admitted to hospitals for the treatment of metabolic diseases. On the other hand, clinical units with optimal standards for the treatment of pathological conditions in normal-weight patients are often structurally and technologically inadequate for the care of patients with extreme obesity. The aim of this book is to focus on the pathophysiological and rehabilitative aspects of disabling obesity, highlighting multidisciplinary rehabilitation interventions as key to counteracting the disabling aspects of complicated obesity.